Sirnaomics Investor Relations Material
Latest events
H2 2024
27 Mar, 2025
H1 2024
30 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sirnaomics Ltd
Access all reports
Sirnaomics Ltd is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference (RNAi) therapeutics. The company specializes in developing RNA-based drugs for the treatment of diseases in areas such as oncology, fibrosis, and other serious conditions. Its platform integrates proprietary delivery technologies designed to enhance the targeting and effectiveness of RNAi-based treatments. Sirnaomics Ltd conducts research, clinical development, and regulatory activities as part of its product advancement strategy. The company is headquartered in Suzhou, China, and its shares are listed on the HKEX.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
2257
Country
🇭🇰 Hong Kong